• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Integrated 2D/3D mammography improves breast cancer detection

bys25qthea
April 27, 2013
in Chronic Disease, Obstetrics, Oncology
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD

1. Compared to 2D mammography alone, integrated 2D and 3D mammography facilitated detection of more breast cancers in asymptomatic women. 

2. Less false positives occurred with integrated mammography than with conventional 2D mammography alone.   

Evidence Rating Level: 2 (Good) 

Study Rundown: This study found that integrated 2D and 3D mammography, or 2D mammography combined with digital breast tomosynthesis with 3D images, detected more breast cancers than 2D mammography alone and was associated with a lower incidence of false positive findings. These results are timely given recent investigations characterizing the problem of breast cancer overdiagnosis associated with population-level mammography screenings. Strengths of this investigation include a large sample size (n=7,292) and within-subject comparisons of mammography method that allowed each woman to serve as her own control. Future investigations might employ a randomized controlled design to evaluate the long-term effects of integrated mammography on morbidity and mortality.

Click to read the study in The Lancet Oncology 

RELATED REPORTS

Giredestrant plus everolimus improves progression-free survival in treatment-resistant breast cancer

Historical redlining associated with lower breast cancer screening across urban neighborhoods

Relevant Reading: Overview of the evidence on digital breast tomosynthesis in breast cancer detection

FDA approvedFor breast cancer: Etcamah (camizestrant), Sep 4, 2026→

In-Depth [prospective comparative study].  This study assessed screening outcomes using integrated 2D and 3D mammography versus 2D mammography alone in a cohort of 7,292 asymptomatic Italian women at average risk for breast cancer (ages ≥48 years). Each participant received both 2D and 3D mammography. Outcomes included cancers detected, false positives, and incremental cancer detection.

Overall, integrated mammography yielded a detection rate of 8.1 per 1,000 screens (95% CI: 6.2-10.4) while 2D mammography alone provided a detection rate of 5.3 cancers per 1,000 screens (CI: 3.8-7.3, p<0.0001) such that the incremental improvement in cancer detection rate attributable to method was 2.7 cancers per 1,000 screens (CI: 1.7-4.2). False-positive findings were recorded in 2% (CI: 1.6-2.3) of patients with 2D mammography only and in 1% (CI: 0.8-1.3) of patients with integrated mammography (p<0.0001).

By Caroline Huang and Leah Hawkins

More from this author: One third of breast cancer survivors report pain 5-7 years after treatment, Varenicline reduces post-quit smoking relapses, Severe maternal childhood abuse associated with autism in offspring, 233 million women projected to lack modern contraceptives by 2015, Reminder intervention increases colorectal cancer screening rates, After-school program increases physical activity in overweight children, School-based therapy reduces asthma symptoms

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: Breast Cancermammography
Previous Post

Insurance status affects treatment of early stage breast cancer

Next Post

The PROVE IT trial: High-dose statin regimen reduces mortality after ACS [Classics Series]

RelatedReports

A middle-aged woman looks thoughtfully at an abstract representation of cells and a statin pill, symbolizing breast cancer and medication usage.
Oncology

Giredestrant plus everolimus improves progression-free survival in treatment-resistant breast cancer

October 5, 2026
A middle-aged woman looks thoughtfully at an abstract representation of cells and a statin pill, symbolizing breast cancer and medication usage.
Oncology

Historical redlining associated with lower breast cancer screening across urban neighborhoods

September 13, 2026
Sleep disorders collage: an engraved pillow and rumpled sheet with a dark sleep mask, a paper crescent moon and a teal ribbon
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
Breast cancer care collage: a calm woman in a turtleneck sweater beside a folded paper crane and a small white pill bottle
Chronic Disease

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

August 13, 2026
Next Post

The PROVE IT trial: High-dose statin regimen reduces mortality after ACS [Classics Series]

Chromosomal analysis not cost-effective in evaluation of recurrent miscarriage

Children with cancer exposed to home medication errors

Children with cancer exposed to home medication errors

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Use of colchicine is not associated with reduced cardiovascular events among Chinese adults starting urate-lowering therapy
  • ARO-DIMER-PA can Significantly Lower LDL-C and Triglycerides in Patients with Mixed Hyperlipidemia
  • CCTA-guided PCI noninferior to IVUS-guided PCI for target-vessel failure
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.